Delivery Order SPE2DX22D0010-SPE2D826FAY32
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,863.96 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 8, 2025, with an ultimate completion date of November 10, 2025. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and runs through December 2026. The award was made on a competitive basis with no set-aside designation....
- The Defense Logistics Agency Medical Supply Chain awarded a $184,771.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 8, 2025, with an ultimate completion date of the same day. This competitively awarded contract, with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,790.80 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $62,781.60 to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a non-competitive award to the pharmaceutical distributor and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $343,401.38 to AmerisourceBergen Drug Corp on November 5, 2025, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order will be fulfilled at the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $134,830.88 to AmerisourceBergen Drug Corp on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The award was made competitively with no...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAY32Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,786.02 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order represents one of numerous transactions under AmerisourceBergen's prime vehicle with DLA, which enables the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical supply needs through open competition, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The work is performed at the company's Corporate Office location in Conshohocken, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 11/10/25 |